CDW stock trades 12.48 percent below its yearly high

CDW stock (ISIN US12514G1085) closed at USD 146.16 on Nasdaq on September 23, 2026, down 0.86 percent from the prior close. The second-quarter 2026 earnings comparison remains the central valuation reference, with non-GAAP EPS at USD 2.91 against consensus of USD 2.80.

Q2 earnings beat consensus

Zacks reported that CDW's second-quarter 2026 non-GAAP EPS exceeded consensus by USD 0.11. Quarterly net sales reached USD 6.57 billion, up 10.0 percent year over year, while constant-currency revenue increased 9.9 percent.

The figures give the stock a measurable earnings cushion, but the share price still sits below its yearly peak. That combination places more weight on the durability of demand than on a single quarterly beat.

Barclays trims its target

On September 21, 2026, Barclays lowered its CDW price target from USD 150 to USD 148 and kept an Equalweight rating, according to MarketScreener. The revised target is USD 1.84 above the September 23 close, equal to 1.26 percent.

MarketBeat lists a consensus Moderate Buy rating and an average target of USD 150.38. The consensus target is USD 4.22 above the close, or 2.89 percent, a narrower gap than the 14.10 percent distance to the 52-week high would suggest.

Stock stays below yearly high

CDW's September 23 market capitalization was USD 18,672,378,480, while its 52-week range was USD 97.12 to USD 167.00. The closing price therefore stood 12.48 percent below the upper end of that range, keeping the chart comparison more demanding than the quarterly revenue growth alone.

Nasdaq close sets the reference

CDW stock closed at USD 146.16 on Nasdaq on September 23, 2026, with a daily change of minus 0.86 percent. CDW provides technology products and services to businesses, government agencies, educational institutions and healthcare organizations, according to AAII.

More news and analyses on CDW stock